LivaNova Corp (LIVN) - יתרות מזומנים למניה אחת

Patents and FDA approvals protect the unique neurostimulators of LivaNova PLC, creating high barriers to entry. Partnerships with cardiac surgery clinics enhance technological synergy. Fluctuations in cash per share within historical data on the GURU.Markets chart demonstrate liquidity, where the value of 10.20 reflects the metric's balance. The expansion strategy in the vagus nerve stimulation niche ensures a steady cash flow.
פילוחים אנליטיים של חברת LivaNova PLC

This indicator reflects the amount of net cash per ordinary share, allowing for an objective assessment of the issuer's financial resilience to external shocks. The trend in liquid assets per share demonstrates the ability of LivaNova PLC (LIVN) to fund intensive R&D for the creation of VNS systems to combat depression without resorting to costly debt capital.